Post-prostatectomy Impotence May Eventually Be Treated with Gene Therapy
Monday, 28 April 2003
NEW YORK (Reuters Health) - Neurotrophic factor gene therapy could offer a solution to the problem of erectile dysfunction after prostatectomy, if findings from a new animal study pan out.
read more
|
Long-term Evidence on Prostate Brachytherapy, Cryoablation Encouraging
Monday, 28 April 2003
CHICAGO (Reuters Health) - Brachytherapy is a safe and effective alternative to radical prostatectomy in men with low-risk prostate cancer, according to data presented here at the annual scientific meeting of the American Urological Association. Also, cryoablation seems to offer another option.
read more
|
Sildenafil Has Only Moderate Effects on Cardiopulmonary Responses During Stress
Friday, 18 April 2003
NEW YORK (Reuters Health) - The pulmonary and hemodynamic effects of the erectile dysfunction (ED) drug sildenafil vary by age and health status but are generally minimal, results of a study in the April issue of The Journal of Urology suggest.
read more
|
American Medical Systems Expands Commitment to Erectile Restoration Market With Acquisition of Line of Urological Prostheses
Monday, 07 April 2003
MINNEAPOLIS--(BUSINESS WIRE)--April 7, 2003--American Medical Systems Holdings Inc. (Nasdaq:AMMD) announced it is expanding its leadership in prosthetic urology by acquiring the Dura II(R) line of erectile restoration products from Endocare Inc.
read more
|
Sildenafil Safe, Effective for Type 1 Diabetic Men with Erectile Dysfunction
Wednesday, 12 March 2003
NEW YORK (Reuters Health) - Sildenafil significantly improves erectile difficulties in men with type 1 diabetes and is well tolerated, according to a report in the February issue of Diabetes Care.
read more
|
Glaxo, Bayer Win EU Approval for Viagra Rival
Friday, 07 March 2003
LONDON (Reuters) - Viagra, the blue diamond-shaped pill that has transformed the treatment of impotence, will face a fresh challenge in Europe after regulators approved a new rival made by Britain's GlaxoSmithKline Plc and Germany's Bayer AG on Friday.
read more
|
Glaxo, Bayer Win EU Approval for Viagra Rival
Friday, 07 March 2003
LONDON (Reuters) - Viagra, the blue diamond-shaped pill that has transformed the treatment of impotence, will face a fresh challenge in Europe after regulators approved a new rival made by Britain's GlaxoSmithKline Plc and Germany's Bayer AG on Friday.
read more
|
Italian Court Upholds Viagra Patent
Friday, 31 January 2003
FLORENCE, Italy (Reuters Health) - Italy's highest appeals court has ruled in favour of Pfizer Inc. in a case that will prevent pharmacists from making pirated generic versions of the erectile dysfunction drug Viagra.
read more
|
Lilly to Launch Cialis for Impotence in Britain Next Week
Tuesday, 28 January 2003
LONDON (Reuters Health) - Eli Lilly said on Monday it would launch its erectile dysfunction drug Cialis (tadalafil) in Britain next week, signalling the start of a battle for a potential multi-billion dollar market so far dominated by Pfizer's Viagra (sildenafil).
read more
|
Novel Erectile Dysfunction Drug Superior to Sildenafil
Wednesday, 22 January 2003
NEW YORK (Reuters Health) - Palatin Technologies Inc. said on Wednesday that its sexual dysfunction drug candidate PT-141 induced a satisfactory erection in at least 80% of the subjects enrolled in a phase IIa trial of 24 patients who previously experienced an inadequate response to Pfizer Inc.'s sildenafil citrate (Viagra).
read more
|
Tadalafil Safe and Effective in Impotent Diabetic Men
Thursday, 16 January 2003
NEW YORK (Reuters Health) - The phosphodiesterase type 5 (PDE5) inhibitor tadalafil is effective in the treatment of erectile dysfunction in men with diabetes, according to researchers in North America and Spain.
read more
|
Sildenafil Can Stimulate Platelet Aggregation if Atherosclerosis is Present
Thursday, 16 January 2003
NEW YORK (Reuters Health) - A new finding may explain why a small minority of men experience MI or stroke following the use of sildenafil (Viagra; Pfizer) for erectile dysfunction.
read more
|
Pfizer to Act Against Italian Pharmacists Over Pirated Viagra Sales
Thursday, 16 January 2003
FLORENCE, Italy (Reuters Health) - Italy's Pfizer affiliate is taking action against a large number of pharmacists who are accused of breaking patent laws by making customized versions of the erectile dysfunction drug Viagra, the company said on Thursday.
read more
|
Laparoscopic Rectal Resection may Increase Risk of Sexual Dysfunction in Men
Friday, 10 January 2003
NEW YORK (Reuters Health) - In men with rectal cancer, laparoscopically assisted resection is more likely to cause sexual dysfunction than conventional open resection, according to a recent report. In women, the two approaches are comparable in this regard.
read more
|
Sildenafil Helpful in Men with Antidepressant-related Sexual Dysfunction
Tuesday, 31 December 2002
NEW YORK (Reuters Health) - In men with sexual difficulties associated with serotonin reuptake inhibitor (SRI) antidepressant therapy, sildenafil improves erectile function and overall satisfaction, researchers report in the January 1st 2003 issue of the Journal of the American Medical Association.
read more
|
Erectile Dysfunction (ED) 
